Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE1, PHASE2
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Condition: Nonsmall Cell Lung Cancer
NCT02981108
A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.